Bleeding prediction scores for patients with VTE
| Ref . | Variables . | Attributed points . | Risk categories . |
|---|---|---|---|
| 34 | mOBRI score | ||
| Age ≥65 y | 1 | Low: 0 point | |
| History stroke | 1 | ||
| History GI bleeding | 1 | ||
| Recent MI | 1 | ||
| Renal insufficiency | 1 | ||
| Diabetes | 1 | ||
| Anemia | 1 | ||
| 32 | Kuijer score | ||
| Age ≥60 y | 1.6 | Low: 0 point | |
| Female sex | 1.3 | Moderate: >0 and <3 | |
| Malignancy | 2.2 | High: ≥3 | |
| 33 | RIETE score | ||
| Age >75 y | 1 | Low: 0 point | |
| Recent bleeding | 2 | Moderate: 1-4 points | |
| Cancer | 1 | High: >4 points | |
| Creatinine >1.2 mg/dL | 1.5 | ||
| Anemia | 1.5 | ||
| PE at baseline | 1 | ||
| 4 | ACCP score | ||
| Age >65 y | 1 | Low: 0 point | |
| Age >75 y | 1 | Moderate: 1 point | |
| Previous bleeding | 1 | High: ≥2 points | |
| Cancer | 1 | ||
| Metastatic cancer | 1 | ||
| Renal failure | 1 | ||
| Liver failure | 1 | ||
| Thrombocytopenia | 1 | ||
| Previous stroke | 1 | ||
| Diabetes | 1 | ||
| Anemia | 1 | ||
| Antiplatelets | 1 | ||
| Poor anticoagulation | 1 | ||
| Comorbidity/reduced functional capacity | 1 | ||
| Recent surgery | 1 | ||
| Frequent falls | 1 | ||
| Alcohol abuse | 1 | ||
| 36 | VTE-Bleed score | ||
| Cancer | 2 | Low: <2 point | |
| Uncontrolled hypertension in men | 1 | High: ≥2 | |
| Anemia | 1.5 | ||
| History of bleeding | 1.5 | ||
| Age ≥60 y | 1.5 | ||
| Renal dysfunction | 1.5 |
| Ref . | Variables . | Attributed points . | Risk categories . |
|---|---|---|---|
| 34 | mOBRI score | ||
| Age ≥65 y | 1 | Low: 0 point | |
| History stroke | 1 | ||
| History GI bleeding | 1 | ||
| Recent MI | 1 | ||
| Renal insufficiency | 1 | ||
| Diabetes | 1 | ||
| Anemia | 1 | ||
| 32 | Kuijer score | ||
| Age ≥60 y | 1.6 | Low: 0 point | |
| Female sex | 1.3 | Moderate: >0 and <3 | |
| Malignancy | 2.2 | High: ≥3 | |
| 33 | RIETE score | ||
| Age >75 y | 1 | Low: 0 point | |
| Recent bleeding | 2 | Moderate: 1-4 points | |
| Cancer | 1 | High: >4 points | |
| Creatinine >1.2 mg/dL | 1.5 | ||
| Anemia | 1.5 | ||
| PE at baseline | 1 | ||
| 4 | ACCP score | ||
| Age >65 y | 1 | Low: 0 point | |
| Age >75 y | 1 | Moderate: 1 point | |
| Previous bleeding | 1 | High: ≥2 points | |
| Cancer | 1 | ||
| Metastatic cancer | 1 | ||
| Renal failure | 1 | ||
| Liver failure | 1 | ||
| Thrombocytopenia | 1 | ||
| Previous stroke | 1 | ||
| Diabetes | 1 | ||
| Anemia | 1 | ||
| Antiplatelets | 1 | ||
| Poor anticoagulation | 1 | ||
| Comorbidity/reduced functional capacity | 1 | ||
| Recent surgery | 1 | ||
| Frequent falls | 1 | ||
| Alcohol abuse | 1 | ||
| 36 | VTE-Bleed score | ||
| Cancer | 2 | Low: <2 point | |
| Uncontrolled hypertension in men | 1 | High: ≥2 | |
| Anemia | 1.5 | ||
| History of bleeding | 1.5 | ||
| Age ≥60 y | 1.5 | ||
| Renal dysfunction | 1.5 |
ACCP, American College of Chest Physicians; GI, gastrointestinal; MI, myocardial infarction; mOBRI, Modified Outpatient Bleeding Risk Index; Ref, reference; RIETE, Registro Informatizado Enfermedad Trombo Embólica.